Xsome Biotech
Xsome Biotech seeks to develop exosome therapeutics and novel drug delivery carriers for a variety of diseases. The company is a lead candidate (XO101 lung stem cell based secretome) and has gained IND approval for treating patients with ARDS. Xsome Biotech's ResEV platform technology allows precise delivery of drugs to the lung paranchyma via inhalation. There are several fold of enhancement when compared to liposomes. We have also pioneered the use of EVs for lung regeneration.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Xsome Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Xsome Biotech
1 distinct titles indexed · top 1 shown.
- 1senior director
Sign up to unlock all 1 contacts at Xsome Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Xsome Biotech
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.